Literature DB >> 17495539

Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193.

Helen M R Robinson, Sigrid Bratlie-Thoresen, Robert Brown, David A F Gillespie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17495539     DOI： 10.4161/cc.6.10.4225

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Authors:  Jacquelyn J Bower; Yingchun Zhou; Tong Zhou; Dennis A Simpson; Sonnet J Arlander; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

2.  Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

Authors:  J J Bower; G F Karaca; Y Zhou; D A Simpson; M Cordeiro-Stone; W K Kaufmann
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

3.  Decatenation of DNA by the S. cerevisiae Sgs1-Top3-Rmi1 and RPA complex: a mechanism for disentangling chromosomes.

Authors:  Petr Cejka; Jody L Plank; Christopher C Dombrowski; Stephen C Kowalczykowski
Journal:  Mol Cell       Date:  2012-08-09       Impact factor: 17.970

4.  Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.

Authors:  Maria Arroyo; Ana Cañuelo; Jesús Calahorra; Florian D Hastert; Antonio Sánchez; Duncan J Clarke; J Alberto Marchal
Journal:  FEBS J       Date:  2020-03-20       Impact factor: 5.542

5.  Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.

Authors:  Xingyue He; Jessica Riceberg; Sai M Pulukuri; Steve Grossman; Vaishali Shinde; Pooja Shah; James E Brownell; Larry Dick; John Newcomb; Neil Bence
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.

Authors:  Nicola Lockwood; Silvia Martini; Ainara Lopez-Pardo; Katharina Deiss; Hendrika A Segeren; Robert K Semple; Ian Collins; Dimitra Repana; Mathias Cobbaut; Tanya Soliman; Francesca Ciccarelli; Peter J Parker
Journal:  Cancer Res       Date:  2022-05-03       Impact factor: 13.312

7.  3EZ,20Ac-ingenol, a catalytic inhibitor of topoisomerases, downregulates p-Akt and induces DSBs and apoptosis of DT40 cells.

Authors:  Yasuaki Fukuda; Masahiro Kanbe; Manami Watanabe; Katsuaki Dan; Keiichi Matsuzaki; Susumu Kitanaka; Shohei Miyata
Journal:  Arch Pharm Res       Date:  2013-04-18       Impact factor: 4.946

8.  A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest.

Authors:  Katharina Deiss; Nicola Lockwood; Michael Howell; Hendrika Alida Segeren; Rebecca E Saunders; Probir Chakravarty; Tanya N Soliman; Silvia Martini; Nuno Rocha; Robert Semple; Lykourgos-Panagiotis Zalmas; Peter J Parker
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

Review 9.  Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.

Authors:  Joyce H Lee; James M Berger
Journal:  Genes (Basel)       Date:  2019-10-30       Impact factor: 4.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.